The long-awaited early results of the first clinical trial of bone-marrow transplant in children with recessive dystrophic epidermolysis bullosa (RDEB), carried out at the University of Minnesota in the USA, have now been published...

Minnesota BMT trial the early results

This news article (DebRA News, autumn 2010) covers the work of Prof Irwin McLean at the University of Dundee, College of Life Sciences. He uses the new and promising technology called SiRNA to switch off the mutated defective copy of the keratin gene in EBS. Read more to find out where the research is at and how close it is to finding an effective treatment for EBS.

Focus on EB Simplex - a treatment in sight?